EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tracing down the updates on Ebola virus surges: An update on anti-ebola therapeutic strategies

Shiza Malik, Yasir Waheed iD

Journal of Translational Internal Medicine · 02.09.2023 · 11 (3) · 216-225

DOI: 10.2478/jtim-2023-0100 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Translational Internal Medicine, online erschienen am 02.09.2023. Verfasst von Shiza Malik und 1 weiteren Autor:innen. Beteiligte Einrichtung: Bridging Health Foundation, Rawalpindi, Punjab 46000, Pakistan. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ebola virus (EBOV) related health complications have presented a great threat to the healthcare system in the endemic regions. The outbreaks of 2013-2016 and 2018-2020 brought along a huge healthcare burden for the afected communities. Knowing the seriousness of the matter, a series of research experiments have been actively carried out to devise efective therapeutics, drugs, and vaccination protocols against the Ebola virus disease (EVD) in the past decade. The purpose of this piece of literature is to shed light on vaccination protocols being clinically evaluated for EVD. A methodological approach has been adopted to gather relevant data from the latest publications. The compiled data include the molecular mechanistic insights into Ebola infection and a brief overview of diferent vaccination strategies: inactivated and DNA vaccines, virus-like particles and replicons, reverse genetic and recombinant approaches, entry, ion, and gene expression inhibitors, and some repurposed drugs. This data will help the scientific community to get a comprehensive overview of therapeutic interventions against Ebola that could be related to modifying EBOV vaccines and designing other antiviral vaccinations. Having said that, further work in modern therapeutic design is pertinent to tackle and lessen the healthcare burden expected from such outbreaks in the future.

Schlagwörter

Stichwörter der Autor:innen

anti-viral agentsdrugsebola virusebola virus diseasenovel drugstherapeutic approachesvaccines

Autor:innen und Institutionen

  • Bridging Health Foundation, Rawalpindi, Punjab 46000, Pakistan.
  • Office of Research, Innovation, and Commercialization (ORIC), Shaheed Zulfiqar Ali Bhutto Medical University (SZABMU), Islamabad 44000, Pakistan.
  • Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Byblos 1401, Lebanon.

ORCID-Profile: Yasir Waheed

Zitieren

APA

Malik, S., & Waheed, Y. (2023). Tracing down the updates on Ebola virus surges: An update on anti-ebola therapeutic strategies. Journal of Translational Internal Medicine, 11(3), 216-225. https://doi.org/10.2478/jtim-2023-0100

Vancouver

Malik S, Waheed Y. Tracing down the updates on Ebola virus surges: An update on anti-ebola therapeutic strategies. Journal of Translational Internal Medicine. 2023;11(3):216-225. doi:10.2478/jtim-2023-0100

BibTeX
@article{Malik2023,
  author = {Malik, Shiza and Waheed, Yasir},
  title = {Tracing down the updates on Ebola virus surges: An update on anti-ebola therapeutic strategies},
  journal = {Journal of Translational Internal Medicine},
  year = {2023},
  volume = {11},
  number = {3},
  pages = {216--225},
  doi = {10.2478/jtim-2023-0100}
}
Kostenlos starten →